CTAB

It is used in various products such as throat lozenges and antiseptic topical gels and creams for a range of purposes. As a processing aid or auxiliary/ancillary, it can be used as a surfactant in the downstream vaccine manufacturing process, for both bacterial polysaccharide vaccines and viral vaccines (e.g. influenza).

CTAB is crucial in breaking up cell membrane, as it initiates cell lysis to isolate antigenic material. It protects from co-precipitated membrane lipids, allowing for efficient antigen isolation with high yields.

CTAB is also employed in isolation/extraction of DNA and in manufacturing of novel Gene Therapies, e.g. as a non-viral vector.

More about CTAB in vaccines.

Uniform quality

Our FeF® CTAB USP/NF product has proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds). It is effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations.

The uniform quality of our products – and of our customers’ products – is ensured by our efficient quality management systems, dedicated equipment, well established processes and rigorous laboratory quality control.

Pharmaceutical Grade

FeF® CTAB USP/NF

CAS No. 57-09-0.

Consists of Hexadecyl trimethyl ammonium bromide. Contains approx. 99% active ingredients.

Please note that product Item no. 7800023 is only manufactured to order.

Documentation and services

• European Drug Master File (ASMF)
• GMP Certificate (enter Certificate number DK API-H 00073316 and choose Denmark in the country field list)
• Certificate of Analysis (current version of pharmacopoeia)
• Datasheet
• Customer audits
• Stability results
• Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, animal testing, etc.)
• Reach
• Change Notification Statement
• Pre-filled Supplier Questionnaire
• Impurity profile
• Description of the manufacturing process
• Process flowchart
• Packaging details
• Quality Agreements